Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 The distribution of molecular markers.

From: Adjuvant therapy for T3N0 rectal cancer in the total mesorectal excision era- identification of the high risk patients

Molecular markers N
P21  
   - 28
   + 29
   ++ 43
   +++ 22
CD44/v6  
   - 72
   + 27
   ++ 20
   +++ 3
EGFR  
   - 71
   + 27
   ++ 16
   +++ 8
Neu  
   - 81
   + 26
   ++ 12
   +++ 3
P53  
   - 45
   + 27
   ++ 27
   +++ 23
PCNA  
   <= 50% 32
   >50% 90
Total 122